Perkins Capital Management’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70,000	Closed	-$281K	–	92
2023 Q4	$281K	Sell	70,000 -197,164	-74%	-$555K	0.24%	74
2023 Q3	$731K	Sell	267,164 -300	-0.1%	-$1.4K	0.72%	44
2023 Q2	$1.79M	Sell	267,464 -7,500	-3%	-$45.5K	1.56%	22
2023 Q1	$1.75M	Sell	274,964 -2,300	-0.8%	-$9.39K	1.65%	20
2022 Q4	$685K	Sell	277,264 -7,800	-3%	-$25.7K	0.72%	42
2022 Q3	$655K	Sell	285,064 -6,386	-2%	-$21.8K	0.73%	44
2022 Q2	$901K	Buy	291,450 +11,600	+4%	+$35.4K	0.93%	39
2022 Q1	$1.02M	Sell	279,850 -250	-0.1%	-$912	0.83%	45
2021 Q4	$1.09M	Buy	280,100 +124,800	+80%	+$666K	0.73%	50
2021 Q3	$980K	Sell	155,300 -10,100	-6%	-$68.8K	0.61%	48
2021 Q2	$1.32M	Buy	165,400 +25,500	+18%	+$223K	0.75%	43
2021 Q1	$1.52M	Buy	139,900 +89,900	+180%	+$1.36M	0.88%	40
2020 Q4	$225K	Buy	+50,000	New	+$221K	0.15%	85